Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Common Equity (2020 - 2025)

Historic Common Equity for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to $8.7 million.

  • Healthcare Triangle's Common Equity rose 57997.8% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 57997.8%. This contributed to the annual value of -$5.1 million for FY2024, which is 105055.76% down from last year.
  • Per Healthcare Triangle's latest filing, its Common Equity stood at $8.7 million for Q3 2025, which was up 57997.8% from $10.2 million recorded in Q2 2025.
  • Over the past 5 years, Healthcare Triangle's Common Equity peaked at $17.6 million during Q3 2022, and registered a low of -$5.1 million during Q4 2024.
  • In the last 5 years, Healthcare Triangle's Common Equity had a median value of $8.1 million in 2023 and averaged $6.7 million.
  • Its Common Equity has fluctuated over the past 5 years, first tumbled by 105055.76% in 2024, then surged by 177847.36% in 2025.
  • Healthcare Triangle's Common Equity (Quarter) stood at $16.1 million in 2021, then plummeted by 62.57% to $6.0 million in 2022, then plummeted by 91.09% to $538000.0 in 2023, then plummeted by 1050.56% to -$5.1 million in 2024, then surged by 270.63% to $8.7 million in 2025.
  • Its last three reported values are $8.7 million in Q3 2025, $10.2 million for Q2 2025, and $8.6 million during Q1 2025.